Andlauer Healthcare Group Inc., headquartered in Canada, is a prominent player in the healthcare logistics and distribution industry. Founded in 1997, the company has established itself as a leader in providing specialised services for the pharmaceutical and biotechnology sectors, with a strong operational presence across North America. The firm offers a range of core services, including temperature-controlled logistics, warehousing, and distribution, which are tailored to meet the stringent requirements of the healthcare market. Andlauer Healthcare's commitment to quality and compliance sets it apart, ensuring that clients receive reliable and efficient service. With a focus on innovation and customer satisfaction, Andlauer Healthcare Group has achieved significant milestones, solidifying its market position as a trusted partner in healthcare supply chain solutions.
How does Andlauer Healthcare Group Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Air Transport industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Andlauer Healthcare Group Inc.'s score of 27 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Andlauer Healthcare Group Inc. reported total carbon emissions of approximately 80,279,990 kg CO2e for Scope 1, which includes emissions from mobile combustion (about 75,685,310 kg CO2e) and stationary combustion (approximately 4,594,680 kg CO2e). The company also disclosed Scope 2 emissions of about 1,682,960 kg CO2e and Scope 3 emissions totalling approximately 49,624,260 kg CO2e, with significant contributions from fuel and energy-related activities (about 17,901,660 kg CO2e) and upstream transportation and distribution (approximately 31,722,600 kg CO2e). Comparatively, in 2022, the company reported Scope 1 emissions of about 79,808,280 kg CO2e, Scope 2 emissions of approximately 1,712,990 kg CO2e, and Scope 3 emissions of around 52,969,640 kg CO2e. This indicates a slight increase in Scope 1 emissions and a decrease in Scope 3 emissions year-on-year. Despite these figures, Andlauer Healthcare Group Inc. has not set specific reduction targets or initiatives as part of their climate commitments. The emissions data is cascaded from the parent company, Andlauer Healthcare Group Inc., indicating a corporate family relationship that influences their reporting. Overall, while Andlauer Healthcare Group Inc. has made strides in emissions reporting, the absence of defined reduction targets highlights an area for potential improvement in their climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 79,808,280 | 00,000,000 |
| Scope 2 | 1,712,990 | 0,000,000 |
| Scope 3 | 52,969,640 | 00,000,000 |
Andlauer Healthcare Group Inc.'s Scope 3 emissions, which decreased by 6% last year and decreased by approximately 6% since 2022, demonstrating supply chain emissions tracking. A significant portion of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 38% of total emissions under the GHG Protocol, with "Upstream Transportation & Distribution" being the largest emissions source at 64% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Andlauer Healthcare Group Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
